-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The reporter learned on the 15th that the traditional Chinese medicine cholening tablets were officially shipped and went to sea to Toronto
, Canada.
This means that cholening tablets have officially entered the international mainstream drug market
.
, Canada.
This means that cholening tablets have officially entered the international mainstream drug market
.
It is understood that bile ning tablets are Chinese patent medicine tablets made of rhubarb, knotweed, green peel, white grass root, tangerine peel, yujin, hawthorn, etc.
, which can alleviate the clinical symptoms caused by chronic cholecystitis, and have the effect
of relieving liver and choleretic, clearing heat and passing.
, which can alleviate the clinical symptoms caused by chronic cholecystitis, and have the effect
of relieving liver and choleretic, clearing heat and passing.
After 15 months of preparation, preparation and translation of nearly 100 registration application materials, and many communications with Health Canada, in September 2016, the company officially submitted a registration application to Health Canada, and passed the approval process
such as expert review and official announcement at one time.
such as expert review and official announcement at one time.
On December 15, 2016, Cholenin tablets obtained the Canadian Natural Medicine Marketing Authorization (NPN: 80073325).
On July 12, 2019, Shanghai Hutchison Pharmaceutical Co.
, Ltd
.
obtained the certification of production sites outside Canada, becoming a Chinese traditional Chinese medicine manufacturer issued by Health Canada (FSRN: 5000525).
Previously, in October 2018, Health Canada experts came to China for academic exchanges and inspected
the production site of Shanghai Huang Pharmaceutical.
Experts praised
the modern production site conditions of the tablets.
On July 12, 2019, Shanghai Hutchison Pharmaceutical Co.
, Ltd
.
obtained the certification of production sites outside Canada, becoming a Chinese traditional Chinese medicine manufacturer issued by Health Canada (FSRN: 5000525).
Previously, in October 2018, Health Canada experts came to China for academic exchanges and inspected
the production site of Shanghai Huang Pharmaceutical.
Experts praised
the modern production site conditions of the tablets.
In 2022, the company cooperated with importers who landed in Canada and signed a 3-year sales agreement, and in July, the two parties signed the first batch of export contracts
for bile tablets.
for bile tablets.
At the loading and delivery ceremony of Cho Ning tablets exported to Canada, Zhou Junjie, president of Shanghai Huthuang Pharmaceutical, said that for many years, the company has been adhering to the application of scientific exploration and interpretation of the clinical value of traditional Chinese medicine, and striving to
achieve the goal of modernization and internationalization of traditional Chinese medicine.
Now the milestone has
finally been achieved.
In the future, Shanghai Hehuang Pharmaceutical will continue to inherit the classics, keep the integrity and innovation, and make new contributions
to the modernization and internationalization of traditional Chinese medicine.
(End)
achieve the goal of modernization and internationalization of traditional Chinese medicine.
Now the milestone has
finally been achieved.
In the future, Shanghai Hehuang Pharmaceutical will continue to inherit the classics, keep the integrity and innovation, and make new contributions
to the modernization and internationalization of traditional Chinese medicine.
(End)
